Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Celecoxib, METRO PLUS (Tata Memorial Centre, Varanasi), Oral metronomic chemotherapy vs intravenous cisplatin (Tata Memorial), Low-dose nivolumab plus metronomic chemotherapy (Tata Memorial) and the tags subtype-page, head-and-neck.
Shares KEYNOTE-048, Oral tongue and floor of mouth cancer, KEYNOTE-048: pembrolizumab, alone or with chemotherapy, as first treatment for recurrent or metastatic head and neck cancer, Oral cavity cancer (mouth and tongue) and the tags subtype-page, head-and-neck.
Shares PD-L1 expression testing (22C3, SP142, SP263), Paclitaxel / nab-paclitaxel, IMRT / IGRT (modern external beam), Cisplatin and the tags subtype-page, head-and-neck.
Shares Docetaxel, Paclitaxel / nab-paclitaxel, IMRT / IGRT (modern external beam), Cisplatin and the tags subtype-page, head-and-neck.
Shares HPV-positive oropharyngeal cancer, Recurrent and metastatic nasopharyngeal carcinoma, IMRT / IGRT (modern external beam), Cisplatin and the tags subtype-page, head-and-neck.
Shares Nivolumab, IMRT / IGRT (modern external beam), Cisplatin, Pembrolizumab and the tags subtype-page, head-and-neck.
Shares SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam), Cisplatin and the tags subtype-page, head-and-neck.
Shares IMRT / IGRT (modern external beam), Cisplatin and the tags subtype-page, head-and-neck.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.